Cargando…

Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention

Self-monitoring of blood glucose (SMBG) is a core component of diabetes management. However, the International Diabetes Federation recommends that SMBG be performed in a structured manner and that the data are accurately interpreted and used to take appropriate therapeutic actions. We designed a stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scavini, Marina, Bosi, Emanuele, Ceriello, Antonio, Giorgino, Francesco, Porta, Massimo, Tiengo, Antonio, Vespasiani, Giacomo, Bottalico, Davide, Marino, Raffaele, Parkin, Christopher, Bonizzoni, Erminio, Cucinotta, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898142/ https://www.ncbi.nlm.nih.gov/pubmed/22189755 http://dx.doi.org/10.1007/s00592-011-0357-y

Ejemplares similares

Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA randomized trial
por: Bosi, Emanuele, et al.
Publicado: (2013)

Response to Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Bosi, Emanuele, et al.
Publicado: (2013)

The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study
por: Russo, Giuseppina T., et al.
Publicado: (2016)

The Importance of Patient and Family Engagement, the Needs for Self-Monitoring of Blood Glucose (SMBG) – Our Perspectives Learned Through a Story of SMBG Assistive Devices Made by a Husband of the Patient with Diabetes
por: Kimura, Moritsugu, et al.
Publicado: (2022)

8(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG): April 16–18, 2015, Republic of Malta
por: Parkin, Christopher G., et al.
Publicado: (2015)

SAT-649 Comparison of the Accuracy and Concordance of 3 CGM Devices vs SMBG During Aerobic Exercise
por: Henske, Joseph A, et al.
Publicado: (2020)

Effect of a CGMS and SMBG on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus: a Randomized Controlled Trial
por: WEI, Qiong, et al.
Publicado: (2016)

Self monitoring of blood glucose - a survey of diabetes UK members with type 2 diabetes who use SMBG
por: Barnard, Katharine D, et al.
Publicado: (2010)

Proportion and predictors of SMBG use among type 2 diabetic subjects in three tertiary care hospitals in Dhaka City
por: Nayeem, Jannatul, et al.
Publicado: (2021)

Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial
por: Parsons, Sharon, et al.
Publicado: (2017)

Patients’ and family members’ knowledge, attitudes and perceived family support for SMBG in type 2 diabetes: a fuzzy-set qualitative comparative analysis
por: Zhao, Qian, et al.
Publicado: (2022)

Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol
por: Zheng, Mingyue, et al.
Publicado: (2020)

Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol
por: Dallosso, Helen M, et al.
Publicado: (2012)

Effect of structured self‐monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non‐insulin treated Type 2 diabetes: the SMBG Study, a 12‐month randomized controlled trial
por: Parsons, S. N., et al.
Publicado: (2019)

Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen
por: Rigacci, Luigi, et al.
Publicado: (2014)

Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
por: Lamacchia, Olga, et al.
Publicado: (2018)

Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation: A Case Report
por: Martinenghi, Sabina, et al.
Publicado: (2015)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
por: Innocenti, Rolando, et al.
Publicado: (2018)

Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: A PRISMA-compliant meta-analysis
por: Liu, Shu-Lan, et al.
Publicado: (2017)

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients
por: Cattaneo, Carlo, et al.
Publicado: (2020)

Diagnostic sensitivity of thyroid autoantibodies assessed in a population-based, cross-sectional study in adults
por: Bosi, Emanuele, et al.
Publicado: (2010)

A Case of Myxoid Liposarcoma of the Retroperitoneum: A Challenging Tumour for Diagnosis and Treatment
por: Grasso, Emanuele, et al.
Publicado: (2014)

Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation
por: Ferrario, Lucrezia, et al.
Publicado: (2021)

PRISMA: the instruments
por: Jones, A
Publicado: (1992)

Effects of Safinamide on Pain in Fluctuating Parkinson’s Disease Patients: A Post-Hoc Analysis
por: Cattaneo, Carlo, et al.
Publicado: (2017)

Optimizing Insulin Glargine Plus One Injection of Insulin Glulisine in Type 2 Diabetes in the ELEONOR Study: Similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Evidences of +896 A/G TLR4 Polymorphism as an Indicative of Prevalence of Complications in T2DM Patients
por: Balistreri, Carmela Rita, et al.
Publicado: (2014)

Prismas : revista de historia intelectual.
Publicado: (1997)

INtegration of care for reaching targetS In Diabetic patiEnts: Design of the INSIDE Study
por: Comaschi, Marco, et al.
Publicado: (2019)

Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson’s Disease: A Post-Hoc Analysis
por: Cattaneo, Carlo, et al.
Publicado: (2015)

Impact of the 8(th) Edition of the AJCC-TNM Staging System on Estimated Cancer-Specific Survival in Patients Aged 45–54 Years at Diagnosis with Differentiated Thyroid Carcinoma: A Single Center Report
por: Maggiore, Riccardo, et al.
Publicado: (2021)

Blinded by PRISMA: Are Systematic Reviewers Focusing on PRISMA and Ignoring Other Guidelines?
por: Fleming, Padhraig S., et al.
Publicado: (2014)

PRISMA 2020 and PRISMA-S: common questions on tracking records and the flow diagram
por: Rethlefsen, Melissa L., et al.
Publicado: (2022)

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews
por: Rethlefsen, Melissa L., et al.
Publicado: (2021)

PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews(*)
por: Rethlefsen, Melissa L., et al.
Publicado: (2021)

Prismas ópticos : aplicaciones clínicas /
Publicado: (1996)

Quality of Diabetes Care Predicts the Development of Cardiovascular Events: Results of the AMD-QUASAR Study
por: Rossi, Maria C.E., et al.
Publicado: (2011)

Costos paramétricos Prisma /
por: González Meléndez, Raúl
Publicado: (2002)

Prisma de México
por: Colín, Mario
Publicado: (1972)

PRISMA statement and PROSPERO
por: Bernardo, Wanderley Marques
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1cu3k1a4kp0ninsieje3i7t3et